Back to news

DigitalOcean gains on analyst upgrade, AI product momentum, and approaching earnings

Investivoq PriceTracker

DigitalOcean Holdings (DOCN) is up 6.8% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied to a mix of bullish positioning ahead of DigitalOcean’s November 3, 2026 earnings report, continued enthusiasm around its recent AI-agent product rollout, and a recent analyst upgrade. While no single same-day catalyst stands out clearly, investors seem to be leaning into the company’s AI growth narrative after strong prior guidance.

Details:

  • DigitalOcean said on October 20 that it will report third-quarter 2026 results before the market opens on November 3, putting a near-term catalyst in focus.
  • In its latest quarterly materials, the company raised its full-year 2026 revenue outlook and highlighted rapid growth in AI customer ARR and million-dollar customer ARR.
  • Over the past month, DigitalOcean launched Managed Agents, Agent Droplets, and new agent learning and data services, reinforcing its push to become an AI-native cloud platform.
  • Piper Sandler upgraded the stock to Overweight on October 21, which could still be supporting sentiment after a recent pullback.

    • Sources:

    DigitalOcean Investor Relations, TipRanks, StreetInsider

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $DOCN Insider Trading Activity

    DOCN Insider Trades

    $DOCN insiders have traded $DOCN stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales.

    Here’s a breakdown of recent trading of $DOCN stock by insiders over the last 6 months:

    • INDUSTRIES HOLDINGS LLC ACCESS has made 0 purchases and 2 sales selling 3,300,000 shares for an estimated $495,990,000.
    • MATT STEINFORT (Chief Financial Officer) has made 0 purchases and 3 sales selling 45,000 shares for an estimated $6,570,500.
    • WARREN JENSON sold 20,000 shares for an estimated $2,952,400
    • PADMANABHAN T SRINIVASAN (Chief Executive Officer) has made 0 purchases and 3 sales selling 22,788 shares for an estimated $2,933,043.
    • CHERIE BARRETT (SVP, Chief Accounting Officer) has made 0 purchases and 2 sales selling 8,441 shares for an estimated $1,011,174.
    • HILARY SCHNEIDER sold 4,338 shares for an estimated $678,376
    • WARREN J ADELMAN sold 4,200 shares for an estimated $520,854

    To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.

    EARLY ACCESS
    Receive DOCN Data Alerts
    Real-time alerts on filings, insider trades, and market signals — before everyone else.
    Get Alerts →

    $DOCN Hedge Fund Activity

    We have seen 306 institutional investors add shares of $DOCN stock to their portfolio, and 259 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    • JPMORGAN CHASE & CO added 13,850,206 shares (+inf%) to their portfolio in Q2 2026, for an estimated $2,174,897,848
    • BLACKROCK, INC. removed 3,185,629 shares (-26.6%) from their portfolio in Q2 2026, for an estimated $500,239,321
    • TWO SIGMA INVESTMENTS, LP added 1,697,290 shares (+896.4%) to their portfolio in Q2 2026, for an estimated $266,525,448
    • WELLINGTON MANAGEMENT GROUP LLP removed 1,383,571 shares (-46.8%) from their portfolio in Q2 2026, for an estimated $217,262,154
    • ALLIANCEBERNSTEIN L.P. removed 1,351,038 shares (-59.2%) from their portfolio in Q2 2026, for an estimated $212,153,497
    • JACOBS LEVY EQUITY MANAGEMENT, INC removed 884,663 shares (-96.8%) from their portfolio in Q2 2026, for an estimated $138,918,630
    • UBS GROUP AG removed 864,592 shares (-58.8%) from their portfolio in Q2 2026, for an estimated $135,766,881

    To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.

    $DOCN Price Targets

    Multiple analysts have issued price targets for $DOCN recently. We have seen 9 analysts offer price targets for $DOCN in the last 6 months, with a median target of $184.0.

    Here are some recent targets:

    • Raimo Lenschow from Barclays set a target price of $184.0 on 07/08/2026
    • Mark Zhang from Citigroup set a target price of $185.0 on 07/08/2026
    • Radi Sultan from UBS set a target price of $155.0 on 07/08/2026
    • Kingsley Crane from Canaccord Genuity set a target price of $200.0 on 06/11/2026
    • Jackson Ader from Keybanc set a target price of $200.0 on 06/03/2026
    • Gabriela Borges from Goldman Sachs set a target price of $179.0 on 05/07/2026
    • James Fish from Piper Sandler set a target price of $155.0 on 05/06/2026

    This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.